MediPharm Labs Corp. (MEDIF)

Market Cap	26.90M
Revenue (ttm)	29.16M
Net Income (ttm)	-7.43M
Shares Out	n/a
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	57,500
Average Volume	110,061
Open	0.0655
Previous Close	0.0609
Day's Range	0.0609 - 0.0655
52-Week Range	0.0370 - 0.0850
Beta	0.56
RSI	49.78
Earnings Date	Mar 28, 2025

About MediPharm Labs

MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, develops, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll canna...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2015
• Employees: 161
• Stock Exchange: OTCMKTS
• Ticker Symbol: MEDIF

Financial Performance

In 2024, MediPharm Labs's revenue was 41.96 million, an increase of 26.92% compared to the previous year's 33.06 million. Losses were -10.69 million, -18.26% less than in 2023.

Financial numbers in CAD